Table 4.
Mortality results of wild, pyrethroid-resistant Anopheles gambiae sensu lato in experimental huts in Covè, southern Benin treated with pyrethroid-PBO ITNs, and pirimiphos-methyl IRS applied alone and in combination.
Treatment | Total females caught | Total dead | % mortality* | 95% CIs |
---|---|---|---|---|
Trial 1 | ||||
Untreated net | 664 | 22 | 3a | 2–5 |
Olyset Plus | 511 | 114 | 22b | 19–26 |
Bendiocarb IRS | 556 | 87 | 16c | 13–19 |
Olyset Plus + Bendiocarb IRS | 288 | 95 | 33d | 28–38 |
P-methyl IRS | 531 | 411 | 77e | 74–81 |
Olyset Plus + P-methyl IRS | 304 | 178 | 59f. | 53–64 |
Trial 2 | ||||
Untreated net | 581 | 12 | 2u | 1–3 |
PermaNet 3.0 | 488 | 127 | 26v | 22–30 |
Bendiocarb IRS | 575 | 80 | 14w | 11–17 |
PermaNet 3.0 + Bendiocarb IRS | 233 | 89 | 38x | 32–44 |
P-methyl IRS | 450 | 350 | 78y | 74–82 |
PermaNet 3.0 + P-methyl IRS | 223 | 122 | 55z | 48–61 |
Results are presented separately for the trials involving Olyset Plus (Trial 1) and PermaNet 3.0 (Trial 2).
*For each trial, values on this column sharing a superscript letter do not differ significantly, p > 0.05, logistic regression.